Crossref

1. Management of chronic viral hepatitis in the hematological patient

- Laura Ambra Nicolini

- Emanuela Zappulo

- Claudio Viscoli

- Malgorzata Mikulska

2. Adoptive immune transfer from donors offers Anti-HBV protection to HBsAb-negative patients after Allo-HSCT

- Jinhua Ren

- QiaoXian Lin

- Qi Chen

- Jingjing Xu

- Dabin Chen

- Renli Chen

- Kangni Lin

- Haojie Zhu

- Chenjing Ye

- Xiaofeng Luo

- Shaozhen Chen

- Hui Kong

- Qiong Lin

- Nan Li

- Xu Lin

- Zhizhe Chen

- Jianda Hu

- Ting Yang

3. Immune phase transition under steroid treatment

- Sonali Priyadarshini Nayak

- Susmita Roy

4. Recurrence and influencing factors of hepatitis B surface antigen seroclearance induced by peginterferon alpha-based regimens

- Rui Lu

- Meng Zhang

- Zi-Han Liu

- Miao Hao

- Yan Tian

- Mei Li

- Feng-Ping Wu

- Wen-Jun Wang

- Juan-Juan Shi

- Xin Zhang

- Xiao-Li Jia

- Zi-Cheng Jiang

- Xue-Mei Li

- Guang-Hua Xu

- Ya-Ping Li

- Shuang-Suo Dang

5. The possible role of interleukin-35 and its therapeutic potential in pemphigus

- Soheil Tavakolpour

- Forough Kheiry

- Hajar Sadat Mirsafaei

- Meisam Akhlaghdoust

6. Iranian guideline for rituximab therapy in pemphigus patients

- Maryam Daneshpazhooh

- Kamran Balighi

- Hamidreza Mahmoudi

- Soheil Tavakolpour

- Robabeh Abedini

- Tahereh Soori

- Amir‐Houshang Ehsani

- Maryam Ghiasi

- Pedram Noormohammadpour

- Narges Ghandi

- Vahideh Lajevardi

- Ali Sadeghinia

- Maryam Nasimi

- Arghavan Azizpour

- Cheyda Chams‐Davatchi

7. Liver Illness and Psoriatic Patients

- Marco Fiore

- Sebastiano Leone

- Alberto Enrico Maraolo

- Emilio Berti

- Giovanni Damiani

8. Immune response to occult hepatitis B virus infection among hemodialysis patients: A review

- Ali Mussa

- Nor Hayati Ismail

- Nazmul Huda Syed

- Mustafa Talib

- Alaa Siddig

- Rosline Hassan

- Rohimah Mohamud

- Nik Haszroel Hysham Nik Hashim

9. SARS-CoV-2 and chronic hepatitis B: Focusing on the possible consequences of co-infection

- Shahrzad Shoraka

- Seyed Reza Mohebbi

- Seyed Masoud Hosseini

- Amir Ghaemi

- Mohammad Reza Zali

10. Tumor Necrosis Factor-α-308 G/A Polymorphisms and Risk of Hepatocellular Carcinoma: A Meta-Analysis

- Soheil Tavakolpour

- Shahnaz Sali

11. Not all TNF inhibitors in rheumatoid arthritis are created equal: important clinical differences

- Priyanka Vashisht

- James O’dell

12. Risk of HBV reactivation in psoriasis vulgaris patients receiving biological agent therapy

- Ayşegül Tel Kankılıç

- Ömer Karakoyun

- Erhan Ayhan

13. Determination of reactivation rate and risk factors for Hepatitis B virus reactivation in low-positive cases: A retrospective cohort study

- Hitoshi Yonezawa

- Shingo Tanaka

- Momoko Furuya

- Koji Yamada

- Koichi Asanuma

- Yoshihiro Fujiya

- Koji Miyanishi

- Satoshi Takahashi

- Junji Kato

14. Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy

- Shigeru Kusumoto

- Luca Arcaini

- Xiaonan Hong

- Jie Jin

- Won Seog Kim

- Yok Lam Kwong

- Marion G. Peters

- Yasuhito Tanaka

- Andrew D. Zelenetz

- Hiroshi Kuriki

- Günter Fingerle-Rowson

- Tina Nielsen

- Eisuke Ueda

- Hanna Piper-Lepoutre

- Gila Sellam

- Kensei Tobinai

15. Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19

- Caterina Sagnelli

- Antonello Sica

- Massimiliano Creta

- Alessandra Borsetti

- Massimo Ciccozzi

- Evangelista Sagnelli

16. Durability of Antibody Response Against Hepatitis B Virus for a Decreased Crowd: A Retrospective Polycentric Cohort Study from a 10-Year Follow-Up Clinical Study

- Pei He

- Jie Xia

- Peixin Zhang

- Wensu Yang

- Zhaoxin Xia

- Ping Liu

- Yi Zhu

- Yaping Fang

- Zhenhua Zhang

- Jilu Shen

17. The safety and efficacy of immune checkpoint inhibitors in patients with advanced cancers and pre-existing chronic viral infections (Hepatitis B/C, HIV): A review of the available evidence

- G. Tapia Rico

- M.M. Chan

- K.F. Loo

18. Pemphigus trigger factors: special focus on pemphigus vulgaris and pemphigus foliaceus

- Soheil Tavakolpour

19. Icaritin‐induced immunomodulatory efficacy in advanced hepatitis B virus‐related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival

- Shu‐Kui Qin

- Qing Li

- Jian Ming Xu

- Jun Liang

- Ying Cheng

- Ying Fan

- Jun Jiang

- Hao Ye

- Huimin Tao

- Lian Li

- Limin Zheng

- Zhaohui Wei

- Shu Li

- Kun Meng

- Bin Ye

- Yan Sun

20. Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study

- Nayana Sudevan

- Manish Manrai

- T V S V G K Tilak

- Harshit Khurana

- Harikrishnan Premdeep

21. Impact of Hepatitis B Infection on Patient and Graft Survival After Kidney Transplantation

- Anissa Paschereit

- Vivien Greese

- Kayo Sakurayama

- Michael Duerr

- Fabian Halleck

- Lutz Liefeldt

- Mira Choi

- Klemens Budde

- Marcel G. Naik

22. Chronic lymphocytic leukemia and infection risk in the era of targeted therapies: Linking mechanisms with infections

- Talal Hilal

- Juan C. Gea-Banacloche

- Jose F. Leis

23.

24. Toward cure chronic hepatitis B infection and hepatocellular carcinoma prevention: Lessons learned from nucleos(t)ide analogues therapy

- Soheil Tavakolpour

- Hajar Sadat Mirsafaei

- Somayeh Elkaei Behjati

- Mojtaba Ghasemiadl

- Meisam Akhlaghdoust

- Shahnaz Sali

25. Management of Patients With Hepatitis C Virus, Monoclonal Gammopathy of Undetermined Significance, and Multiple Myeloma

- Alisse Hannaford

- David Del Bello

- Siyang Leng

- Ajai Chari

- Ponni Perumalswami

- Douglas Dieterich

- Andrea Branch

26. Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study

- María Buti

- María L. Manzano

- Rosa M. Morillas

- Montserrat García-Retortillo

- Leticia Martín

- Martín Prieto

- María L. Gutiérrez

- Emilio Suárez

- Mariano Gómez Rubio

- Javier López

- Pilar Castillo

- Manuel Rodríguez

- José M. Zozaya

- Miguel A. Simón

- Luis E. Morano

- José L. Calleja

- María Yébenes

- Rafael Esteban

- Vincent Wong

27. Anti-TNF alfa kullanan hastalarda hepatit B reaktivasyonunun değerlendirilmesi

- İlkay BOZKURT

- Ahmet BEKTAŞ

28. Tenofovir Alafenamide: A New Drug With Various Ambiguous Aspects in Treatment of Chronic Hepatitis B Infection

- Soheil Tavakolpour

- Mohammad Darvishi

- Shahnaz Sali